Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia by Jarius, Sven, Martínez-García, Pedro, Hernandez, Adelaida León, Brase, Jan Christoph, Borowski, Kathrin, Regula, Jens Ulrich, Meinck, Hans Michael, Stöcker, Winfried, Wildemann, Brigitte, Wandinger, Klaus-Peter

Get full text

Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2 by Prat, Aleix, Brase, Jan Christoph, Cheng, Yuan, Nuciforo, Paolo, Paré, Laia, Pascual, Tomás, Martínez, Débora, Galván, Patricia, Vidal, Maria, Adamo, Barbara, Hortobagyi, Gabriel N., Baselga, José, Ciruelos, Eva

Get full text

Peroxiredoxins 3 and 4 Are Overexpressed in Prostate Cancer Tissue and Affect the Proliferation of Prostate Cancer Cells in Vitro by Ummanni, Ramesh, Barreto, Frederico, Venz, Simone, Scharf, Christian, Barett, Christine, Mannsperger, Heiko A, Brase, Jan Christoph, Kuner, Ruprecht, Schlomm, Thorsten, Sauter, Guido, Sültmann, Holger, Korf, Ulrike, Bokemeyer, Carsten, Walther, Reinhard, Brümmendorf, Tim H, Balabanov, Stefan

Get full text

A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer by Prat, Aleix, Tsai, Yi-Hsuan, Pascual, Tomás, Paré, Laia, Adamo, Barbara, Vidal, Maria, Brasó-Maristany, Fara, Galván, Patricia, Brase, Jan Christoph, Rodrik-Outmezguine, Vanessa, Johnston, Stephen, Ciruelos, Eva, Parker, Joel S

Get full text

Abstract A38: Maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer by Kuner, Ruprecht, Sültmann, Holger, Fälth, Maria, Pressinotti, Nicole Chui, Brase, Jan Christoph, Balaguer-Puig, Sabrina, Schäfer, Georg, Bartsch, Georg, Steiner, Eberhard, Klocker, Helmut

Get full text

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial by Martin, Miguel, Brase, Jan C, Calvo, Lourdes, Krappmann, Kristin, Ruiz-Borrego, Manuel, Fisch, Karin, Ruiz, Amparo, Weber, Karsten E, Munarriz, Blanca, Petry, Christoph, Rodriguez, Cesar A, Kronenwett, Ralf, Crespo, Carmen, Alba, Emilio, Carrasco, Eva, Casas, Maribel, Caballero, Rosalia, Rodriguez-Lescure, Alvaro

Get full text

Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test by Kronenwett, Ralf, Bohmann, Kerstin, Prinzler, Judith, Sinn, Bruno V, Haufe, Franziska, Roth, Claudia, Averdick, Manuela, Ropers, Tanja, Windbergs, Claudia, Brase, Jan C, Weber, Karsten E, Fisch, Karin, Müller, Berit M, Schmidt, Marcus, Filipits, Martin, Dubsky, Peter, Petry, Christoph, Dietel, Manfred, Denkert, Carsten

Get full text

Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation by Börno, Stefan T, Fischer, Axel, Kerick, Martin, Fälth, Maria, Laible, Mark, Brase, Jan C, Kuner, Ruprecht, Dahl, Andreas, Grimm, Christina, Sayanjali, Behnam, Isau, Melanie, Röhr, Christina, Wunderlich, Andrea, Timmermann, Bernd, Claus, Rainer, Plass, Christoph, Graefen, Markus, Simon, Ronald, Demichelis, Francesca, Rubin, Mark A, Sauter, Guido, Schlomm, Thorsten, Sültmann, Holger, Lehrach, Hans, Schweiger, Michal R

Get full text

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative b... by Martin, Miguel, Brase, Jan C., Ruiz, Amparo, Prat, Aleix, Kronenwett, Ralf, Calvo, Lourdes, Petry, Christoph, Bernard, Philip S., Ruiz-Borrego, Manuel, Weber, Karsten E., Rodriguez, César A., Alvarez, Isabel M., Segui, Miguel A., Perou, Charles M., Casas, Maribel, Carrasco, Eva, Caballero, Rosalía, Rodriguez-Lescure, Alvaro

Get full text

Abstract P3-06-12: Predicting residual risk of recurrence after neoadjuvant chemotherapy- a retrospective analysis of EndoPredict® in the GeparTrio trial by Loibl, Sibylle, Brase, Jan C, Gade, Stephan, Huober, Jens, Krappmann, Kristin, Engels, Knut, Fend, Falko, Pfitzner, Berit Maria, Hilfrich, Joern, Thomssen, Christoph, Holzhausen, Hans Juergen, Darb-Esfahani, Silvia, Schem, Christian, Mehta, Keyur, Kronenwett, Ralf, von Minckwitz, Gunter, Denkert, Carsten

Get full text

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence by Rodriguez-Lescure, Alvaro, Brase, Jan C, Calvo, Lourdes, Alvarez, Isabel M, Perou, Charles M, Weber, Karsten E, Petry, Christoph, Kronenwett, Ralf, Martin, Miguel, Caballero, Rosalia, Casas, Maribel, Ruiz-Borrego, Manuel, Rodriguez, Cesar A, Segui, Miguel A, Ruiz, Amparo, Carrasco, Eva, Prat, Aleix, Bernard, Philip S

Get full text

From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis by Brase, Jan C, Kronenwett, Ralf, Petry, Christoph, Denkert, Carsten, Schmidt, Marcus

Get full text

From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis by Brase, Jan C, Kronenwett, Ralf, Petry, Christoph, Denkert, Carsten, Schmidt, Marcus

Get full text